• 医学文献
  • 知识库
  • 评价分析
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
  • 临床诊疗知识库
  • 中医药知识库
  • 机构
  • 作者
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

医学文献 >>
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
热搜词:
换一批

靶向人转录因子GLI1基因的RNAi真核表达载体的构建与鉴定

Construction and identification of RNAi eukaryotic expression vectors targeting human transcription factor glioma-associated oncogene homolog 1

摘要:

目的 利用pGCsi-U6-GFP质粒构建干扰人转录因子GLI1基因的小发夹RNA(shRNA)表达载体,并进行干扰活性鉴定.方法 根据GenBank中GLI1cDNA的序列,设计并合成3条GLI1siRNA,分别克隆至质粒载体pGCsi-U6-GFP中构建重组质粒,转化大肠杆菌DH5a,扩增后提取质粒,行PCR及测序鉴定.脂质体转染法将鉴定正确的3个重组质粒pGCsi-U6-GLI1siRNA-1、pGCsi-U6-GLI1siRNA-2、pGCsi-U6-GLI1siRNA-3及作为阴性对照质粒的pGCsi-U6-GLI1siRNA-C分别与过表达质粒pEGFP-N1-GLI1共转染HEK293细胞株,48 h后收集细胞,半定量RT-PCR及蛋白质印迹法检测各组细胞GH1 mRNA及蛋白的表达,鉴定筛选出最佳干扰质粒.结果 3个重组质粒pGCsi-U6-GLI1siRNA-1、pGCsi-U6-GLI1siRNA-2、pGCsi-U6-GLI1siRNA-3均扩增出预期大小(369 bp)的片段,经测序证实与设计合成的序列完全一致.3个重组质粒转染HEK29细胞后细胞GLI1mRNA表达量分别为0.290±0.011、0.421 ±0.018、0.373±0.018,蛋白表达量分别为0.318 ±0.026、0.433±0.021、0.381±0.018,均显著低于阴性对照质粒转染细胞的0.834±0.022及0.818±0.024(P=0.000).GLI1 mRNA表达抑制率分别达65.8%、50.7%、55.7%,蛋白表达抑制率分别为63.9%、48.3%、53.9%,以pGCsi-U6-GLI1siRNA-1的干扰作用最强.结论 成功构建了靶向GLI1的shRNA表达载体,筛选出具有最佳干扰效果的质粒,为进一步研究GLI1基因功能奠定了基础.

更多
abstracts:

Objective To construct RNAi eukaryotic expressing vectors of human transcription factor glioma-associated oncogene homolog 1 (GLI1) with pGCsi-U6-GFP plasmid and to identify its activity in interfering GLI1.Methods Three GLI1siRNA targeting GLI1 were designed and synthesized according to the GLI1cDNA sequence in GeneBank,and then were cloned into pGCsi-U6-GFP to construct the recombinant plasmids,and transformed into E.coli DH5a,then it was amplified and plasmids were extracted,which were further confirmed by PCR reaction and DNA sequencing,pGCsi-U6-siRNA-C was negative as control wector.Then recombinant plasmids pGCs-U6-GLI1siRNA-1,pGCs-U6-GLI1 siRNA-2,pGCs-U6-GLI1siRNA-3 pGCsi-U6-siRNA-C and a eukaryotic over-expression vector pEGFP-N1-GLI1 were co-transfected into HEK293 cells by Lipofectamine 2000 respectively.The ceils were collected at 48 h after transfection.Semi-quantitative RTPCR and Western Blot were performed to detect the expression of GLI1 mRNA and protein to screen the optimal vector which had the best interfering effect.Results A 369 bp fragment was amplified from all three recombinant plasmids,(pGCs-U6-GLI1 siRNA-1,pGCs-U6-GLI1 siRNA-2,pGCs-U6-GLIlsiRNA-3),showing that synthesized shRNA oligonucleotide fragments were correctly inserted into three recombinant plasmids,which were further confirmed by sequencing.Expression levels of GLIlmRNA and protein in cells in pGCs-U6-GLI1 siRNA-1,pGCs-U6-GLI1 siRNA-2,pGCs-U6-GLI1 siRNA-3 were 0.290 ± 0.011,0.421 ± 0.018,0.373 ±0.018,and 0.318 ± 0.026,0.443 ± 0.021,0.381 ± 0.018,which were significantly lower than those in negative control group (0.834 ± 0.022,0.818 ± 0.024,P =0.000),the inhibitory rates were 65.8 %,50.7%,55.7%,and 63.9%,48.3%,53.9%.The interfering efficacy of pGCs-U6-GLIlsiRNA-1 was the strongest among the three recombinant plasmids.Conclusions RNAi eukaryotic vectors pGCs-U6-GLIlsiRNA-1,pGCs-U6-GLI1 siRNA-2,pGCs-U6-GLI1 siRNA-3 are successfully constructed and the optimal vector is identified,and this can provide a solid experimental foundation for further functional study of GLI1 gene.

More
作者: 郭杰芳 [1] 高军 [1] 龚燕芳 [1] 金晶 [1] 吴红玉 [1] 满晓华 [1] 李兆申 [1]
期刊: 《中华胰腺病杂志》2013年13卷2期 118-121页 ISTIC
栏目名称: 论著
DOI: 10.3760/cma.j.issn.1674-1935.2013.02.011
发布时间: 2013-08-05
基金项目:
国家自然科学基金 上海市科委医学引导类项目
  • 浏览:549
  • 下载:40

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

扩展文献

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷